ATG:biosynthetics GmbH

Weberstr. 40
79249 Merzhausen
Germany

Phone: +49 (0) 761/ 8889424
Fax: +49 (0) 761/ 8889425
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

ATG:biosynthetics is a synthetic biology and molecular biotech company located in Merzhausen near Freiburg/ Germany.

Mammalian display system tANCHOR for exposing antigens on the cell surface for direct immunization from cell culture expressing the antigene. Protein-Protein interaction experiments are feasible:

VITAGO! SARS-CoV2 ACE2 - RBD binding assay indicating neutralizing antibodies in case the ACE2-RBD interaction is prevented.Selective for alpha, beta, gamma, delta and lambda RBD variants !

Investors are welcome for financing the market entry.

We are experts in combinatorial gene design and multi-gene expression. We offer multi-gene and multi-peptide expression products and services for R&D:

• Multi-protein recombineering and expression systems for E.coli, insect and mammalian cells (flexiTec)

• Tailor-made expression systems for other (micro)organisms through our ToggleTec systems

• Multi-peptide library design tool as well as multi-peptide library construction and expression system (PepID)

• Synthetic bioinformatics for complex gene design/optimization projects, e.g. Gene intelligence solution EvoMAG for multi-parametric gene / gene cluster design and optimization in diverse target organisms (metabolic engineering, etc.)

• Gene synthesis of individual genes and gene clusters

• Synthetic biology projecting and consulting from design to (multi-gene) expression strategy

ATG is also looking for strategic partnerships and outsourcing projects that aim at developing and marketing high-potential applications, e.g. DNA- and protein based vaccines.

Last update of this entry: September 28, 2021